ZIM
FPRX

Zacks Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Zacks Investment Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-51,241
Closed -$1.93M – 629
2021
Q1 		$1.93M Buy
+51,241
New +$1.28M 0.03% 287

Zacks Investment Management's FPRX Position: Q2 2021 in Review

Zacks Investment Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 51,241 shares — an estimated $1.93M sold.

Zacks Investment Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $1.93M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Zacks Investment Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Zacks Investment Management sold 51,241 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $1.93M.
  • Zacks Investment Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Zacks Investment Management's Five Prime Therapeutics, Inc. position peaked at $1.93M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Zacks Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.